Green Fresh Biotechnology Company Limited

Green Fresh Biotechnology Company Limited

1084.HK
Green Fresh Biotechnology Company LimitedHK flagHong Kong Stock Exchange
0.73
HKD
-0.01
- -
633.34MMarket Cap
Green Fresh Biotechnology Company Limited
1084.HK
(Hong Kong Stock Exchange)

Recent

price

0.73

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.6
0.69
1.09
1.39
0.92
1.16
1.71
1.42
1.18
- -
Revenue per Share
0.06
0.1
0.1
0.13
0.07
0.1
0.24
-0.1
0.07
- -
Basic EPS, GAAP
0.03
-0.04
-0.02
-0.09
-0.05
-0.02
-0.08
0.1
0.1
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.06
0.03
0.04
0.03
- -
- -
Dividend per Share
0.08
0.17
0.27
0.47
0.41
0.51
0.72
0.61
0.67
- -
Book Value per Share
0.09
0.21
0.32
0.83
0.67
0.7
0.89
0.77
0.87
- -
Tangible Book Value per Share
800
800
800
641
806
819
823
828
836
- -
Basic Weighted Avg Shares
479
553
876
892
739
951
1,411
1,174
989
905
Sales/Revenue/Turnover
15.91
18.76
16.04
15.87
12.58
14.55
20.58
-6.22
11
4.12
Operating Margin (%)
16
19
35
37
37
43
50
47
48
47
Depreciation Expense
48
78
82
84
58
85
199
-85
62
7
Net Income, GAAP
25.65
22.98
27.74
26.97
23.56
24.49
23.58
- -
24.73
24.62
Effective Tax Rate (%)
9.98
14.02
9.39
9.4
7.86
8.91
14.12
-7.27
6.28
0.73
Profit Margin (%)
-74
-28
63
278
229
264
430
300
443
450
Working Capital
57
99
106
56
30
82
91
69
103
102
LT Debt
137
256
357
631
636
705
852
754
850
847
Total Equity
- -
17.83
16.33
12.2
6.93
9.18
16.62
- -
5.89
1.96
Return on Invested Capital (%)
- -
24.16
20.97
16.99
10.66
11.57
20.69
- -
7.63
2.46
Return on Capital (%)
- -
77.32
47.24
32.51
18.33
22.67
39.52
-15.55
11.65
1.16
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.54%
-0.36%
Free Cash Flow
- -
0.2%
-123.69%
Net Income, GAAP
- -
-44.8%
-89.4%
Sales/Revenue/Turnover
- -
7.19%
-8.55%
Total Cash Common Dividend
- -
- -
-57.83%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,174
2024
- -
- -
- -
- -
989
2025
- -
- -
- -
- -
905

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.1
2024
- -
- -
- -
- -
0.07
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.03
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Green Fresh Biotechnology Company Limited engages primarily in the production and sale of seaweed-based and plant-based hydrocolloid products in China and overseas markets. Its core product portfolio includes agar-agar products, carrageenan products, konjac products, and blended products derived from natural seaweed and plant sources, which are widely used as food additives in dairy products, beverages, confectioneries, meat products, jellies, and desserts. The company also produces other related products such as algae powder. Founded in 2001 and headquartered in Hong Kong, Green Fresh Biotechnology operates through subsidiaries in China, including Green Fresh (Fujian) Foodstuff Co., Ltd. The company maintains a strong research and development capability with an independent R&D center focused on innovation and enhancement of product quality and profitability. In recent years, Green Fresh Biotechnology undertook a significant rebranding and name change from Green Future Food Hydrocolloid Marine Science Company Limited to its current name, effective July 2025. This change reflects a strategic shift to better align the brand with its core biotechnology focus. The company has also expanded its product offerings to higher value-added blended products and developed fast-dissolvable agar for use in dairy and health foods, alongside new markets for gel-type air fresheners and beauty products such as face masks. Additionally, Green Fresh is investing in production facility enhancements to improve product quality, cost competitiveness, and sustainability. The company emphasizes the development of 100% bio-based products and is dedicated to leveraging advanced biotechnology to sustain growth and improve returns on investment. Green Fresh Biotechnology operates primarily within the specialty chemicals and materials sector, serving food processing industries with natural hydrocolloid solutions. Its major markets include China and selected overseas regions in Europe. The company's strategic initiatives, including its rebranding and ongoing product innovation, position it to capitalize on the growing demand for natural, high-quality food additives and related biotechnology products. Its controlling shareholders include prominent figures such as Mr. Chan Kam Chung and Mr. Chan Shui Yip, under whose leadership the company continues to pursue technical excellence and market expansion. This comprehensive product range, coupled with recent strategic realignments and R&D investments, reinforces Green Fresh Biotechnology's status as a leading producer of hydrocolloid products in China with expanding global outreach.